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Premature truncation alleles in the ALMS1 gene are a frequent cause of human Alstro ¨m syndrome. Alstro ¨m syndrome is
a rare disorder characterized by early obesity and sensory impairment, symptoms shared with other genetic diseases
affecting proteins of the primary cilium. ALMS1 localizes to centrosomes and ciliary basal bodies, but truncation
mutations in Alms1/ALMS1 do not preclude formation of cilia. Here, we show that in vitro knockdown of Alms1 in mice
causes stunted cilia on kidney epithelial cells and prevents these cells from increasing calcium influx in response to
mechanical stimuli. The stunted-cilium phenotype can be rescued with a 59 fragment of the Alms1 cDNA, which
resembles disease-associated alleles. In a mouse model of Alstro ¨m syndrome, Alms1 protein can be stably expressed
from the mutant allele and is required for cilia formation in primary cells. Aged mice developed specific loss of cilia
from the kidney proximal tubules, which is associated with foci of apoptosis or proliferation. As renal failure is a
common cause of mortality in Alstro ¨m syndrome patients, we conclude that this disease should be considered as a
further example of the class of renal ciliopathies: wild-type or mutant alleles of the Alstro ¨m syndrome gene can
support normal kidney ciliogenesis in vitro and in vivo, but mutant alleles are associated with age-dependent loss of
kidney primary cilia.
Citation: Li G, Vega R, Nelms K, Gekakis N, Goodnow C, et al. (2007) A role for Alstro ¨m syndrome protein, Alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet
3(1): e8. doi:10.1371/journal.pgen.0030008
Introduction
Alstro ¨m syndrome is a rare autosomal recessive disorder
characterized by early onset obesity, type 2 diabetes mellitus,
retinal degeneration, and hearing impairment. Other aspects
of the disease include cardiomyopathy, liver dysfunction,
kidney dysfunction, and a delay in puberty. Renal function
declines with age, and end-stage renal disease is a common
cause of death in Alstro ¨m syndrome patients [1]. Additionally,
enlarged kidneys have been reported in a previously reported
mouse strain with a mutation in Alms1 [2].
The primary cilium is an antenna-like organelle, sur-
rounded by a membrane contiguous with the plasma
membrane [3,4]. Typically, cilia extend several micrometers
from the apical face of the cell, grounded to the cellular
microtubule complex through the basal body. Cilia are
conserved through several eukaryotic phyla, including Caeno-
rhabditis elegans, Chlamydomonas, and vertebrates. Immotile
primary cilia contain a scaffold of nine microtubule doublets
running the length of the axoneme (9 þ 0), whereas motile
cilia contain an additional central microtubule pair (9 þ 2
arrangement). Increasing data demonstrate roles for the
primary cilium in sensory functions. These include mecha-
nosensation of lumenal ﬂow in kidney tubules and trans-
duction of extracellular signaling through the hedgehog, Wnt,
and platelet-derived growth factor receptor pathways [3,4].
Four lines of evidence suggest the hypothesis that renal
failure in Alstro ¨m patients is secondary to a defect in primary
cilia in the kidney. First, mutations in genes that are
implicated in the function of primary cilia are associated
with kidney diseases. Polycystic kidney disease (PKD) is
characterized by progressive development of ﬂuid-ﬁlled cysts,
ultimately leading to end-stage renal failure [5]. Both
autosomal dominant PKD (ADPDK) proteins (Polycystin-1
and  2) are localized to primary cilia and are necessary for
cilia-mediated signaling in response to a ﬂuid-ﬂow stimulus
[6]. Autosomal recessive PKD (ARPKD) protein (ﬁbrocystin)
and nephronophthisis disease proteins, nephrocystin and
inversin, are involved in ciliary protein transport [7,8].
Additionally, mouse strains with genetic lesions in ciliary
proteins lead to cystic kidney disease [9,10]. Second, the
spectrum of phenotypes seen in Alstro ¨m patients is similar to
Bardet-Biedl patients [11], suggesting that mutations in
ALMS1 might cause disease through a similar mechanism to
BBS mutations. It is now well documented that several of the
11 genes mutated in Bardet-Biedl syndrome (BBS) have roles
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localized to centrosome and ciliary basal bodies in vitro
[20,21], consistent with a role in the structure of the basal
body or in the transport of proteins between the cytoplasm
and the ciliary axoneme. Fourth, in vivo phenotypes of Alms1
mutant mice include a lack of sperm ﬂagella, a modiﬁed
ciliary structure, as well as defective rhodopsin transport
through the connecting cilia of photoreceptor cells [2,22].
These data point to a role of ALMS1 in the function of
primary cilia, but no defects in cilia formation were observed
in human dermal ﬁbroblasts from an Alstro ¨m syndrome
patient [21] or in the kidney collecting duct epithelial cells of
a gene-trap Alms1 mutant mouse strain [2]. A possible
resolution of this discrepancy comes from the genetic analysis
of mutations in ALMS1 that have been found in patients. In
all cases, there was at least one allele of ALMS1 that could
encode an N-terminal fragment of the ALMS1 protein before
the presence of a premature stop codon. Moreover, the alleles
in two reported mice models of Alstro ¨m syndrome would also
be predicted to encode the N-terminus of Alms1 [2,22]. Thus,
it is possible that ALMS1 is required for cilia formation, and
that the disease-associated alleles are able to provide at least
part of this activity through expression of the N-terminus of
the protein. In this study, we test whether ALMS1 has a role in
cilia formation or function and provide evidence that renal
failure in Alstro ¨m syndrome patients might be associated
with ciliary dysfunction.
Results
Depletion of Alms1 mRNA and Protein by Short
Interfering RNA Causes Defective Ciliogenesis in Kidney
Cells
To determine whether Alms1 was necessary for cilium
formation and/or function, we used an in vitro model of
kidney cell ciliogenesis and signaling. Mouse inner medullary
collecting duct (mIMCD3) cells form cilia 5 d after conﬂuency
[23]. The cilia can be visualized as long protrusions from the
cell surface using an antibody raised against acetylated
tubulin (Figure 1A). We tested several short interfering
RNA (siRNA) molecules designed against the mouse Alms1
sequence for their effects on formation of cilia in this model.
Cilia were formed normally in the presence of a negative
control siRNA. However, transfection with two siRNA
sequences against Alms1, Alms1a and Alms1b, led to a
markedly different phenotype. The acetylated tubulin stain-
ing on each cell manifested as a single ball of ﬂuorescence,
and very few cells showed the elongated staining typical of
ciliary axoneme (Figure 1A). Both of these siRNA species also
caused a decrease in the Alms1 mRNA level (Figure 1B). In
contrast, two additional siRNAs (Alms1c and Alms1d) did not
affect the pattern of acetylated tubulin staining in the
ciliogenesis assay, nor did they affect the Alms1 mRNA level
(Figure 1A and 1B). To demonstrate that the active siRNA
species also decreased levels of Alms1 protein, we raised an
antiserum in rabbits against the predicted N-terminal 13
amino acids of the open reading frame of Alms1. Using this
antiserum, we detected positive staining at the base of cilia,
consistent with previous reports on the subcellular local-
ization of ALMS1 [21]. The antibody signal was reduced below
detection in the presence of the active siRNA molecules
(Figure 1C).
Loss of Alms1 Does Not Affect Transcriptional Regulation
of Ciliary Genes but Does Disrupt Ciliary
Mechanosensation
Transcriptional proﬁling in Chlamydomonas and in C. elegans
has identiﬁed a set of genes that are regulated during
ciliogenesis [24,25]. As an initial characterization of the role
of Alms1 in the mIMCD3 in vitro model, we asked whether
Alms1 protein was required for the transcriptional response
associated with ciliogenesis. A time course of mIMCD3
ciliogenesis showed a steady rise in the level of Alms1 mRNA
after conﬂuency. This was paralleled by an increase in cilia
length (Figure 2A and 2B). We chose two other cilia-related
genes that have increased mRNA levels during ciliogenesis,
Bbs4 and Ttc10. Bbs4 (BBS gene 4) encodes a protein localized
to the basal body and centrosome that is required for
targeting cargo to the pericentriolar region [13]; Ttc10 (IFT88/
polaris) is required for transport of cargo from basal body to
the distal cilium [26]. Bbs4 and Ttc10 mRNA were upregulated
even when ciliogenesis was disrupted with Alms1a siRNA
(Figure 2B). Moreover, microarray analysis showed that
knockdown of Alms1 by siRNA had no effect on the general
transcription program associated with conﬂuency and cilio-
genesis in the mIMCD3 cells (Figure 2C and Table S1).
We then used this model to ask whether the stunted cilia
formed in limiting amounts of Alms1 were functionally
competent. Cilia on kidney epithelial cells are able to induce
an intracellular calcium signal in response to ﬂuid ﬂow over
the cell surface. Defects in this response are thought to
underlie PKD [27,28]. Full-length cilia formed in the presence
of a control siRNA were able to respond to ﬂow as expected
(Figure 2D). However, the stunted cilia formed in the
presence of the Alms1a siRNA were unable to induce calcium
ﬂux after a ﬂow stimulus.
Taken together, these in vitro results suggest a critical role
of Alms1 in cilia biogenesis of kidney epithelial cells, though
without disruption of the transcriptional program that
accompanies this process. The abnormal cilia formed after
knockdown of Alms1 are characterized by a focal concen-
tration of acetylated tubulin at the cell membrane, and these
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Author Summary
Alstro ¨m syndrome is a rare genetic disorder caused by mutations in
the ALMS1 gene. The disease is characterized by blindness, deafness,
and metabolic disorders. These symptoms are reminiscent of
diseases affecting the primary cilium, a cellular appendage with a
role in sensing changes to the extracellular environment. In addition,
kidney failure is a frequent cause of death in Alstro ¨m syndrome
patients, and recent studies have suggested a causal relationship
between defects in primary cilia and cystic kidney diseases. In this
paper, we show that ALMS1 protein is required to form cilia in
kidney cells. Mutant alleles of the gene that are similar to those seen
in the human disease are able to support cilia formation in cell
culture and in animals. However, a defect in the function of the
disease alleles is uncovered in older mice: cilia are lost from the
kidney cells, and this is associated with an increase in cellular
proliferation and cell death. The data are consistent with a
requirement for ALMS1 in ciliogenesis and suggest inclusion of
Alstro ¨m syndrome among the growing class of cilia-related
pathologies.Figure 1. Suppression of Alms1 Expression Alters Primary Cilium Formation in Kidney Epithelial Cells
(A) Elongated cilia, visualized with staining of acetylated tubulin (green), form normally in mIMCD3 cells after mock-transfection, transfection with a
negative control siRNA, or transfection with two inactive siRNAs directed against Alms1 (Alms1c and Alms1d). Focal staining of acetylated tubulin
without axoneme extension is seen after transfection with two active siRNAs targeting Alms1 (Alms1a and Alms1b).
(B) Real-time PCR analysis with two mouse Alms1 probes recognizing the junctions of exons 1 and 2 and exons 12 and 13, respectively: Alms1a and
Alms1b siRNAs both cause 70%–80% knockdown of Alms1 mRNA; no effect on Alms1 mRNA was seen with the three siRNAs that were inactive in the
ciliogenesis assay.
(C) Alms1a siRNA-treated cells lose endogenous Alms1 protein expression. Acet, acetylated. Scale bars, 10 lm.
doi:10.1371/journal.pgen.0030008.g001
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ﬂux.
A5 9 Fragment of Alms1 Is Sufficient to Rescue Cilia
Formation In Vitro after Knockdown of Endogenous
Alms1 and Can Support Normal Ciliogenesis In Vivo
Reported alleles of ALMS1 in human patients, as well as in
two reported mouse models of the disease, usually encode
premature termination codons in exons 8, 10, and 16
[2,22,29,30]. In these alleles, the 59 terminus of the gene
encodes an intact open reading frame that might give rise to a
partially functional protein. Therefore, we tested whether a
truncated 59 cDNA was able to rescue cilia formation after
Alms1 knockdown. We transfected a mouse Alms1 cDNA
encoding the N-terminal 1,282 amino acids, equivalent to
exons 1–8, into mIMCD3 cells in the presence of the Alms1a
siRNA. The Alms1a siRNA sequence matches the Alms1 gene
39 of the cDNA fragment and so was predicted to affect only
Figure 2. Loss of Alms1 Does Not Affect Transcriptional Changes during Ciliogenesis but Causes Impairment in Flow-Induced Mechanosensation
(A) Confocal microscopic analysis of cilia biogenesis in mIMCD3 cells. Short cilia can be detected at day 3 after transfection. mIMCD3 cells transfected
with Alms1a siRNA have stunted cilia at days 3 and 5. Cells were stained with anti-acetylated tubulin (yellow, cilia) and TO-PRO-3 (red, nuclei).
(B) Suppression of Alms1 does not affect the upregulation of Bbs4 and Ttc10 during ciliogenesis. N, negative siRNA; 1a, Alms1a siRNA; 1b, Alms1b siRNA.
(C) Heat map representation of microarray analysis of mIMCD3 during ciliogenesis. 98 genes with the most dramatic changes in expression showed
approximately equivalent expression changes in the presence of a scrambled siRNA control, or in the presence of specific siRNAs that decreased Alms1
mRNA levels and blocked cilia formation.
(D) Stunted cilia formed in the presence of Alms1a siRNA (red) lack flow-induced Ca2þinflux in mIMCD3 cells, compared with a negative control siRNA
(blue). Representative data are shown for cytosolic calcium change of individual cells in response to mechanical flow. Arrow points to the start of flow.
doi:10.1371/journal.pgen.0030008.g002
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Alms1 and Kidney Ciliogenesisthe levels of the endogenous transcript and not expression of
the cDNA encoding the N-terminus of Alms1. As expected,
transfection with Alms1a siRNA caused focal acetylated
tubulin staining. However, cotransfection of the Alms1 cDNA
with Alms1a siRNA was fully capable of rescuing the cilia
phenotype (Figure 3A). To monitor the effects of cDNA
transfection on knockdown of the endogenous mRNA level,
we used a Taqman assay recognizing the boundary of exons
12 and 13 of the Alms1 mRNA. This assay will detect the
endogenous full-length transcript but not the transfected
cDNA and shows that cotransfection of the cDNA did not
affect knockdown of the endogenous transcript. Conversely,
using a Taqman assay recognizing the 59 of Alms1 mRNA that
detects both the endogenous and cDNA-encoded transcript,
we showed that cotransfection with the siRNA Alms1a did not
affect over-expression of the Alms1 59 cDNA (Figure 3B).
To determine whether a premature truncation allele of the
Alms1 gene can support normal ciliogenesis at endogenous
expression levels, we used primary cells from a mouse strain
with an ethyl nitroso urea–induced, premature truncation
mutation in exon 10 of the Alms1 gene (Figure S1). The Alms1
gene in this mutant strain is predicted to encode the N-
terminal 2,131 amino acids of the mouse Alms1 protein, and
we therefore named the allele Alms1
L2131X/L2131X. Similar
expression of Alms1 mRNA was observed across eight tissues
in wild-type and homozygous Alms1
L2131X/L2131X mice (Figure
3C). In particular, levels of Alms1 mRNA in the kidney of
mutant Alms1
L2131X/L2131X mice are at least as high as in the
wild-typecontrolmice.Inaddition,wedetected mutantAlms1
protein localized at the base of cilia of Alms1
L2131X/L2131X
primary kidney cells (Figure 3D). Thus, despite the presence of
a premature stop codon allele in the Alms1 gene of these mice,
both mRNA and protein were readily detectable. By isolating
primary ﬁbroblasts and kidney cells from Alms1
L2131X/L2131X
mice and wild-type controls, we found that cells from the
Alms1
L2131X/L2131X strain showed normal primary cilia when
compared to wild-type cells (Figure 3E), which is consistent
with previous reports [2,21]. We then tested whether expres-
sion of the mutant Alms1 transcript was required for normal
cilia formation in cells derived from the Alms1
L2131X/L2131X
mouse strain. Knockdown of mutant Alms1 mRNA using a 59
speciﬁc siRNA in the Alms1
L2131X/L2131X embryonic ﬁbroblasts
inhibited ciliogenesis in these cells (Figure 3F), as was seen for
wild-type cells (unpublished data).
Age-Dependent Loss of Primary Cilia and Homeostasis in
Alms1 Mutant Mice
We characterized the phenotype of Alms1
L2131X/L2131X
mouse strain with reference to the metabolic and sensory
defects reported in Alstro ¨m syndrome patients to determine
whether the pathology of the mouse strain resembled that of
human patients. Homozygous mutant mice increased in
weight faster than wild-type controls between 7 and 10 wk
of age, and body composition analysis showed that this
increase was almost entirely explained by an increase in fat
mass (Figure 4A). Histological analysis showed hypertrophy of
white and brown fat adipocytes and steatosis of the liver in
obese mutant mice (Figure 4B). Although one older male
mutant mouse in this cohort of 20 became diabetic, most
mice had normal glucose levels with hyperinsulinemia. Other
serum abnormalities include elevated leptin, triglycerides,
total cholesterol, and HDL cholesterol (Figure S2). Finally, we
noted that the Alms1
L2131X/L2131X strain had defective sperm
formation in the testes and defective rhodopsin transport in
the retina (Figure 4C and 4D). We conclude from these data
that the Alms1
L2131X/L2131X mouse strain is a close genetic
model of human Alstro ¨m syndrome [1], and we proceeded to
analyze whether there were any defects in the kidney cilia that
might relate to renal failure in human patients.
The kidneys of 6-mo-old Alms1
L2131X/L2131X mice contained
multiple dilated tubules in the cortex (Figure 5A). Consistent
with a previous report [2], primary cilia appeared normal in
collecting ducts of the renal medulla. However, we noticed
that some cortex tubules appeared to be almost completely
denuded of cilia in aged Alms1
L2131X/L2131X mutants (Figure 5A
and 5B). To further characterize these tubules, we stained the
kidney sections with Lotus tetragonolobus agglutinin (LTA) as a
proximal tubular marker, and with aquaporin-2 antibody as a
marker of collecting ducts (Figure 5C). In both the wild-type
and Alms1
L2131X/L2131X mutant animals, the aquaporin-2-
labeled collecting duct cells have clear primary cilia as
expected. LTA-labeled proximal tubule cells in the wild-type
animals were also ciliated. In contrast, most of the LTA-
labeled proximal tubules of Alms1
L2131X/L2131X mutants were
not ciliated.
Human PKD is thought to originate from renal tubule
dilatation, secondary to abnormalities in cellular prolifer-
ation and apoptosis. We examined kidney sections from wild-
type and mutant mice with a marker for proliferation, Ki67,
and by TUNEL staining for apoptotic cells (Figure 5D). Sparse
proliferation was seen in wild-type kidney sections. Higher
levels of proliferation were detected in the cortex of kidneys
from Alms1
L2131X/L2131X mice, and this was focused in patches,
perhaps representing convolutions of the same tubule
coming into the plane of sectioning. In most of the cross
sections of dilated tubules, several (20%–50%) of the
epithelial cells were Ki67-positive, and these cells lacked
cilia. We also noted a dramatic increase in kidney epithelial
cell apoptosis in the mutant mice. As with Ki67, it was striking
that TUNEL-positive cells had a nonuniform distribution and
seemed to be clustered within particular tubules, whereas
other tubules appeared identical to wild-type controls. These
changes appeared to compromise kidney function, as
urinanalysis revealed a mild proteinurea in adult
Alms1
L2131X/L2131X mice (Figure 5E). None of the kidney
phenotypes described above (dilated tubules, loss of cilia,
proliferation and apoptosis of epithelial cells, or proteinurea)
was seen in 2-mo-old mice (Figure S3 and unpublished data).
Discussion
ALMS1 is among the largest disease genes identiﬁed today
in the human genome. However, amino acid sequence
analysis identiﬁes only a leucine zipper near the N-terminus,
allowing limited inferences to be made about the function of
this protein. Localization of ALMS1 to the centrosome and
ciliary basal body has been determined using a green
ﬂuorescent protein fusion to its C-terminus, and with an N-
terminal antibody, respectively [20,21]. These data are
consistent with a role for ALMS1 in the function of cilia,
which is supported by the overlapping clinical phenotypes
between Alstro ¨m syndrome and other ciliopathies, especially
BBS. Additionally, mouse models of BBS and Alstro ¨m
syndrome lack sperm ﬂagella and a modiﬁed cilium; and
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Alms1 and Kidney Ciliogenesisshow aberrant transport of rhodopsin, pointing to defective
function of the connecting cilium in photoreceptor cells.
In this paper, we investigated whether Alms1 protein is
required for the formation of cilia and, if so, whether cilia can
be formed in human or mouse cells with a mutated ALMS1/
Alms1 gene. We used an in vitro model of kidney ciliogenesis
to demonstrate that knockdown of Alms1 mRNA caused a
striking alteration in the morphology of cilia: knockdown of
Alms1 caused stunted or focal staining of acetylated tubulin.
The speciﬁcity of the siRNA reagents was conﬁrmed by two
pieces of evidence. First, two siRNAs that were active in
decreasing mRNA expression were also active in decreasing
formation of elongated cilia. Conversely, two additional
Alms1 siRNAs, as well as a negative control siRNA, did not
decrease Alms1 mRNA nor did they affect the ciliary
phenotype. Second, the ciliary phenotype that was induced
by Alms1 siRNA knockdown could be rescued by cotransfec-
tion of a 59 fragment of Alms1 that was not targeted by the
active siRNA. Together these results rule out the possibility
that the cilia phenotype caused by siRNA knockdown was an
off-target effect, and point to a role of Alms1 in the
maintenance or biogenesis of cilia.
Interestingly, previous work had shown that cilia were
formed in cells with mutant ALMS1/Alms1. To reconcile those
ﬁndings with our siRNA knockdown data, we posited a
functional role for the truncated Alms1 protein encoded by
the mutant alleles. Alms1 mRNA in our mutant mouse strain
was present at levels similar to those in wild-type mice,
despite the presence of a premature stop codon. We also
found that the mutant Alms1 protein was detectable and
localized to ciliary basal bodies in cells from these mice, just
as was observed for wild-type Alms1. Additionally, in
unpublished data, immunohistochemistry with the antibody
raised against the N-terminus of Alms1 showed prominent
staining in the mutant pancreatic islets, conﬁrming that
protein could be stably expressed from the mutant allele. To
test whether there was a function for the mutant protein, we
showed that knockdown of the mutant Alms1 mRNA inhibited
ciliogenesis in primary cells from these mice. We also showed
that the ciliary phenotype induced by knockdown of Alms1
could be rescued using a cDNA encoding only the N-terminal
1,282 amino acids of Alms1, conﬁrming that the N-terminus
of Alms1 is sufﬁcient to support cilia formation.
A spectrum of nonsense and frameshift mutations cause
Alstro ¨m syndrome, and all have different effects. However, no
genotype/phenotype correlation has been observed among
human patients [29–31]. Furthermore, two mouse models of
Alstro ¨m syndrome reported to date, as well as a third model
reported in this manuscript, contained alleles that were
predicted to encode the N-terminus of the protein, and the
reported phenotypes are very consistent. Thus, we suggest
that truncation of ALMS1/ Alms1, secondary to mutations in
(predominantly) exons 8, 10, and 16, leads to similar
phenotypes in human and mouse. In particular, we provide
evidence for residual function of the disease-associated
alleles. This residual function of mutant Alms1 alleles might
explain a lack of the more severe developmental phenotypes
described in animal models with mutations of intraﬂagellar
transport (IFT) or kinesin motor proteins [26,32,33].
There is growing support for the ‘‘antenna’’ role of primary
cilium as a key participant in sensing environmental stimuli,
transduction of intracellular signaling, and regulation of
morphogenetic pathways. Studies of BBS patients and BBS
knockout animal models have revealed the role of primary
cilia in sensing of light and olfaction [14,16,17,19]. The kidney
primary cilium, extending from the tubular epithelium into
the lumen, has been implicated in mechanosensation: genetic
or chemical disruption of cilia inhibited intracellular calcium
inﬂux in response to laminar ﬂow [34,35]. Recent studies have
suggested that cilia constitute an essential platform where
signaling processes are initiated. The Hedgehog receptor
Smoothened and the platelet-derived growth factor receptor
alpha localize to the cilium and, in both cases, ciliary
localization is required for signaling transduction [36,37].
We show here that Alms1 is necessary for formation of kidney
epithelial cilia, which in turn are known to be essential for
mechanosensory signaling.
Well-characterized genetic disorders of primary cilia
include the family of PKD, inherited either as ADPKD or
ARPKD traits. While ARPKD is congenital and often causes
fetal or neonatal death, the onset of the ADPKD is mainly in
adulthood with age-dependent progression [5]. Animal
models of PKD have been developed by genetic mutation of
PKD genes [38–41], loss of kidney cilia by inhibition of IFT
components [10,42], or constitutive activation of the Wnt
pathway [43].
Recent data have started to build a connection between
these seemingly unrelated genetic perturbations in PKD, IFT,
and Wnt genes. Localization of PKD proteins has been
observed on, or at the base of, cilia and cilia are dependent on
IFT for protein transport to and from the cytoplasm [44].
Both PKD1 and PKD2 function on cilia to sense lumenal ﬂow
and control cell proliferation. Speciﬁcally, ﬂuid ﬂow over the
cilia increases expression of inversin, which in turn targets
cytoplasmic Dsh, inhibiting the canonical Wnt pathway [45].
It has been proposed that urine ﬂow terminates the canonical
Wnt pathway in favor of the noncanonical Wnt pathway. The
noncanonical Wnt pathway might then maintain planar cell
polarity and restrict cell division in a direction parallel to the
long axis of the tubule. Moreover, BBS proteins have been
shown to directly interact with proteins which regulate
planar cell polarity [46], as well as in ciliary protein transport
Figure 3. N-Terminal Alms1 Protein Can Support Cilia Formation
(A) Cotransfection of Alms1a siRNA-treated cells with a 59 Alms1 cDNA construct rescues primary cilia formation in mIMCD3 cells.
(B) Real-time PCR analysis of Alms1a siRNA and N-terminal Alms1-transfected cells. Upper panel: over-expression of the 59 cDNA does not affect
knockdown of endogenous Alms1 mRNA with Alms1a siRNA. Lower panel: knockdown of endogenous Alms1 mRNA does not affect overexpression of
the 59 cDNA. N, negative control siRNA; cDNA, 59 Alms1 cDNA; 1a, Alms1a siRNA.
(C) Stable expression of Alms1 mRNA from the Alms1
L2131X/L2131X allele. Real-time PCR analysis of Alms1 gene expression in an Alms1
L2131X/L2131X mouse
and a wild-type littermate control.
(D) The N-terminal mouse Alms1 antibody detects Alms1 mutant protein at the ciliary basal body in primary kidney cells from the Alms1
L2131X/L2131X
mouse. Shown are low and high magnifications of the ciliated cells. Arrowheads point out the base of cilia.
(E) Normal appearance of primary cilia in primary fibroblasts (MEF) and primary kidney cells (PKC) from the Alms1
L2131X/L2131X mouse strain.
(F) Inhibition of cilia formation in Alms1a siRNA-treated Alms1
L2131X/L2131X primary fibroblasts. Scale bars, 10 lm.
doi:10.1371/journal.pgen.0030008.g003
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planar cell polarity signaling and lead to disorientated cell
division and cyst formation.
Existing mouse PKD animal models are characterized by the
formation of early-onset cysts in the collecting tubules,
reminiscent of human ARPKD. In contrast, the Alms1 mutant
mouse model presented here shows cilia loss in the proximal
tubules. Further, adult mice progress to a breakdown in
Figure 4. Alms1
L2131X/L2131X Mice Recapitulate Human Alstro ¨m Syndrome
(A) Alms1
L2131X/L2131X mice gain more fat mass than heterozygote or wild-type controls but equivalent lean mass.
(B) Histological examination of Alms1
L2131X/L2131X mice and wild-type littermate control. Insets show oil red O staining of frozen liver sections.
(C) Testis H&E sections show degeneration of seminiferous tubules (arrow), which have reduced numbers of germinal cells. Reduced numbers of sperm
flagella with decreased length are observed in the epididymus of Alms1
L2131X/L2131X mice (anti-acetylated tubulin, green). H&E, hematoxylin-eosin.
(D) Rhodopsin staining in the outer nuclear layer cell bodies is seen in rare cells in the Alms1
L2131X/L2131X animals (arrows) but not in wild-type littermate controls.
Insets illustrate higher magnification images. ONL, outer nuclear layer; IS, inner segment; OS; outer segment. Scale bars, 50 lm.
doi:10.1371/journal.pgen.0030008.g004
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Alms1 and Kidney Ciliogenesismaintenance of kidney epithelial cellular quiescence, with a
dramatic increase in apoptotic and proliferating cells re-
stricted to those tubules that have lost cilia. This is
accompanied by tubular dilatation and mild proteinurea in
older mutant mice. All these phenotypes are similar to clinical
features of ADPKD, making the Alms1
L2131X/L2131X mouse
strain an interesting animal model to study the relation of
cilia loss, altered signaling, and cellular proliferation in the
progression of cystic kidney disease in the proximal tubules.
Initiation of ADPKD is suggested to be dependent on a
Figure 5. Kidney Abnormalities in Alms1 Mutant Mice
(A)H&E-stainedkidneysectionsofa6-mo-oldAlms1
L2131X/L2131Xmouseshowingdilatedcortextubulescomparedwithanage-matchedwild-typecontrol.Lack
ofkidneyciliaisobservedinsometubulesinthecortexofAlms1
L2131X/L2131Xkidney,whereasciliainthemedullaappearnormal.H&E,hematoxylin-eosin;Acet,
acetylated.
(B) Cortex cilia count comparison between Alms1
L2131X/L2131X and controls. 300–400 kidney nuclei were examined for each of six fields of Alms1
L2131X/L2131X
and wild-type controls. The bar chart represents the average and standard deviations of cilia count per 100 kidney cortex epithelial cells from eight mice
per group.
(C) In the cortex of Alms1
L2131X/L2131X kidney, cilia are lost selectively in LTA-labeled tubules but not in aquaporin-2-expressing tubules.
(D) Upper panel: clusters of Ki67-positive proliferating epithelial cells in the Alms1
L2131X/L2131X kidney, potentially lining the same convoluted tubule.
Lower panel: TUNEL staining reveals apoptotic cells in Alms1
L2131X/L2131X kidneys but rarely in a wild-type control. Arrow, whole tubule cross sections were
labeled by TUNEL, suggesting progression of nephropathy in Alms1
L2131X/L2131X mutant kidneys. WT, wild-type.
(E) Urinalysis of 3- to 6-mo-old Alms1
L2131X/L2131X mice and age-matched littermate controls. Urine from Alms1
L2131X/L2131X mice showed slight elevation of
protein levels, p ¼ 0.007. Scale bars, 50 lm.
doi:10.1371/journal.pgen.0030008.g005
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Alms1 and Kidney Ciliogenesissecond somatic mutation in the wild-type allele of PKD1 or
PKD2. Evidence for this hypothesis is controversial as somatic
mutagenesis rates in nontransformed cells are likely to be too
low to explain the high prevalence of bilateral disease in
heterozygous carriers [48,49] and a reduced expression of
PKD1 is sufﬁcient to initiate cystogenesis [41]. In this
recessive model of ciliary dysfunction in the kidney, we also
observe localized expression of the cellular phenotype (cilia
loss, apoptosis, or proliferation). This suggests that in this
model, and perhaps in human late-onset kidney diseases, non-
genetic and/or epigenetic factors are necessary for expression
of the phenotype. The disease-like allele of Alms1, although
functionally able to support cilia formation in vitro, in young
mice and in older mice in the kidney medulla, might reveal a
compromised function in the cortex during aging. We also
note that the expression of the cellular kidney phenotype in
our model is not random but shows a variegated pattern on a
tubule-by-tubule basis. Some tubule cross sections appear to
have normal cilia, and little to no proliferation or apoptosis,
whereas other tubule cross sections show extensive loss of
cilia, sometimes with all or nearly all of the epithelial cells
either proliferating or in apoptosis. The presumed somatic
event, which, in combination with a genetic predisposition,
causes some tubules to appear dysfunctional while neighbor-
ing tubules have a wild-type appearance, is not known.
However, more detailed characterization of the progression
of the phenotype might suggest treatments that maintain
tubular integrity and delay disease.
Materials and Methods
Cell culture and ciliogenesis assay. mIMCD3 cells were obtained
from American Type Culture Collection (www.atcc.org) and cultured
in DMEM/F12 media (Invitrogen, http://www.invitrogen.com) supple-
ment with 10% FBS, 2.5 mM L-glutamine. For cilia formation assay,
50,000 cells were seeded on 12-mm Transwell ﬁlters (Costar). Filters
were collected at day 0, day 1, day 3, day 5, and day 7 after seeding for
RNA isolation and cilia immunostaining.
Knockdown of Alms1 expression by RNAi. We designed siRNA
speciﬁc to Alms1 by online BLOCK-iT RNAi designer (Invitrogen).
These siRNA sequences are: 59-GCTGTATGTAGTCGAATTA-39
(Alms1a); 59-GCCTGATTCCTTGTTTCAA-39 (Alms1b); 59-GCAG
TAGTCTCTTCTGCTT-39 (Alms1c); 59-GCTTCAGCTTTGCT
GAATT-39 (Alms1d). SiRNA were synthesized by Qiagen (http://
www1.qiagen.com). For RNAi transfection, mIMCD3 cells were
seeded as previously described and transfected with Lipofectamine
2000 (Invitrogen) according to manufacturer’s instruction.
DNA constructs. The mouse Alms1 cDNA was generated from
mIMCD3 mRNA. N-terminus (aa: 1–1,282) was cloned into p3XFLAG-
CMV vector (Sigma, http://www.sigmaaldrich.com) to generate N-
Alms1-FLAG plasmid.
RNA isolation and labeling for array analysis. Cells were trans-
fected on day 0 with either a scrambled siRNA control (one of two
siRNAs directed against Alms1) or mock-transfected. Cells were
seeded on day 1 and allowed to reach conﬂuence through day 7. Cilia
were formed in the mock-transfected and scrambled siRNA-trans-
fected cells. Samples were taken for gene expression on days 0, 1, 3, 5,
and 7 for the mock-transfected cells; days 0, 1, 3, and 5 for scrambled
siRNA-transfected cells; and days 1, 3, and 5 for cells transfected with
siRNAs against Alms1. RNA was isolated using the RNeasy Kit from
Qiagen. Total RNA was examined on an Agilent Bioanalyzer (Agilent,
http://www.agilent.com) and the 28S/18S ratio exceeded 2.0 for all
samples. cDNA and cRNA were prepared from 4 lg total RNA
according to standard Affymetrix protocols (http://www.affymetrix.
com/support/technical/manual/expression_manual.affx). The in vitro
transcription kit used was the GeneChip IVT labeling kit (Affyme-
trix). All reactions were processed at the same time by the same
individual. We selected a group of 98 genes that had the highest
relative gene expression change during ciliogenesis in the mock-
transfected cells. The query was: (max expression level for days 0, 1, 3,
5, and 7 for the mock-transfected cells) divided by the maximum (the
minimum expression level over these samples and a cutoff value of
400 arbitrary units). Four hundred units was approximately the 77th
percentile of expression across all 36,000 probesets for a given
sample. We selected the top 98 genes by this ratio (ratio .7.4) and
then clustered the genes based on their expression levels in the
mock-transfected samples. Comparison of this pattern with the
samples that were transfected with either a scrambled or targeted
siRNA showed no signiﬁcant changes in the broad transcriptional
program that was associated with ciliogenesis, suggesting that Alms1
is unlikely to play a role in transcription regulation associated with
ciliogenesis.
Ca
2þ imaging assay. mIMCD3 cells, grown on cover glass, were
transfected with Alms1 RNAi or scrambled control siRNA using
Lipofectamine 2000 (Invitrogen), and cells were grown for 5 more d
to induce cilia formation. Ca
2þ imaging was performed as described
[6]. Brieﬂy, cells were incubated with 5 lM Fura2-AM (Molecular
Probes, Invitrogen) for 30–60 min at 37 8C. Cover glasses were placed
in a laminar ﬂow perfuse chamber (Warner Instruments Corporation,
http://www.warneronline.com). After 20 min equilibration, cells were
perfused with media as described [6] via a local perfusion pipette.
Image of Fura-2 loaded cells with excitation wavelength alternating
between 340 nm and 380 nm were captured by a CCD camera.
Following subtraction of background ﬂuorescence, the ratio of
ﬂuorescence at two wavelengths was analyzed using Metaﬂuor
(Universal Imaging Corporation). All experiments have been
repeated in triplicate and similar results were obtained.
Generation and phenotypic analysis of Alms1 mutant mice. We
identiﬁed Alms1
L2131X/L2131X mice in an ethyl nitroso urea–forward
genetics screen. Mutant mice were generated by successive inter-
crossing of heterozygote Alms1
L2131X animals on a mixed C57Bl6/
NOD genetic background. Body composition was determined by
quantitative magnetic resonance according to protocols supplied by
the manufacturer (Echo Medical Systems, http://www.echomri.com).
All plasma analytes were measured in retinal blood samples. Serum
glucose, cholesterol, HDL, and triglyceride levels were determined by
Olympus AU400e. Leptin and insulin levels were analyzed by ELISA
(Crystal Chemical Incorporated).
Histology and immunohistochemistry. Mice were anesthetized with
Avertin (Sigma, 1.25%, 0.02 ml per gram body weight), perfused with
10% sucrose solution and 4% paraformaldehyde. Tissues were ﬁxed
in 4% paraformaldehyde, processed, and embedded in parafﬁn. 5-lm
tissue sections were processed for hematoxylin-eosin (H&E) and
immunostaining. For routine immunostaining, the sections were
deparafﬁnized with xylene and rehydrated with graded ethanol.
Primary antibodies used in this study were: c-tubulin; acetylated
tubulin (Sigma); b-Galactosidase (Abcam, http://www.abcam.com/
index.html?); ki67 (NeoMarker Rabbit Monoclonal); aquaporin-2
(Santa Cruz Biotechnology, http://www.scbt.com). We generated
polyclonal antibodies to Alms1 by injecting rabbits with the synthetic
peptides MEPEDLPWPDELE, representing amino acids 1–13 of
mouse Alms1. Dilutions were following the manufacturer’s sugges-
tions. Antibodies were visualized by Vectastain immunodetection kit
(Vector Laboratories, Incorporated, http://www.vectorlabs.com). For
indirect immunoﬂoresence, Alexa488 and Texas Red conjugated
secondary antibodies were obtained from Molecular Probes, Incor-
porated.
Isolation and culturing primary ﬁbroblasts and kidney cortical duct
cells. Wild-type and Alms1
L2131X/L2131X embryos were harvested at
embryonic day 12.5 and minced by passage through a syringe with an
18 G needle. Embryonic ﬁbroblasts were cultured in 10% FBS DMEM
medium. For generation of primary kidney epithelial cells, mice
(postnatal day 5) were anesthetized by intraperitoneal injection of
2.5% Avertin. Kidney cortices were dissected by handheld micro-
tome. The slices were dissociated with DMEM containing 1 mg/ml
collagenase. Digested tissues were then passed sequentially through
100-lm and 45-lm sieves, and centrifuged at 1,000 3 g for 10 min at
room temperature. The pellets were resuspended and cultured in
renal epithelial growth medium (REGM Bullet Kit, Cambrex
Bioscience, http://www.cambrex.com).
Supporting Information
Figure S1. Identiﬁcation of Alms1
L2131X/L2131X Strain
(A) Genotyping data for F2 mice derived from outcross of G3 mice
from an ethyl nitroso urea screen on a C57Bl/6 background to NOD,
followed by intercrossing of the F1 offspring. Genotype is marked as
‘‘B’’ for a B6-derived allele, ‘‘H’’ for heterozygote, and ‘‘N’’ for a
NOD-derived allele. Based on the phenotype and genotype data,
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Alms1 and Kidney Ciliogenesisblack shading denotes the included region for the position of the
mutation and gray shading denotes the excluded region. Map
positions refer to public mouse genome assembly M33 (http://www.
ensembl.org/Mus_musculus/index.html).
(B) Resequencing Alms1 gene in mutant mice showing nonsense
mutation at exon 10. Schematic structure of Alms1 was drawn to scale
based on a genomic search of Alms1 cDNA (http://www.genome.ucsc.
edu).
Found at doi:10.1371/journal.pgen.0030008.sg001 (327 KB JPG).
Figure S2. Serum Analytes in Alms1
L2131X/L2131X Mice and Controls
Plasma glucose, triglyceride, insulin, leptin, total cholesterol, and
HDL cholesterol measurements in 60- to 80-d-old and 140- to 170-d-
old Alms1
L2131X/L2131X, Alms1
þ/L2131X , and Alms1
þ/þ mice. Arrow,
diabetic mutant male.
Found at doi:10.1371/journal.pgen.0030008.sg002 (445 KB JPG).
Figure S3. LossofCiliaintheKidneyCortexofAgedAlms1
L2131X/L2131X
Mice
Cilia are lost in the cortex tubules (A) but not in the medulla tubules
(B) in an age-dependent manner. Cilia were stained with an anti-
acetylated tubulin antibody.
Found at doi:10.1371/journal.pgen.0030008.sg003 (2.0 MB JPG).
Table S1. Gene Expression Changes after Knockdown of Alms1
Gene expression levels of 98 genes with the most dramatic changes in
mIMCD3 cells transfected with Alms1 siRNAs compared to a
scrambled siRNA control and a mock-transfected control.
Found at doi:10.1371/journal.pgen.0030008.st001 (126 KB XLS).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
ber for Alms1 mouse cDNA is AF425257 and the RefSeq (http://www.
ncbi.nlm.nih.gov/RefSeq) accession number for Alms1 mouse protein
is NP660258.
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